Leumas, a deeptech manufacturing startup has raised $2.2 million through a seed funding led by Capital 2B, a deeptech fund backed by the Info Edge / Temasek partnership along with other investors Capital-A and Anicut Capital.
The funding will develop its R&D functions, expand its on-demand manufacturing infrastructure and test a pilot rollout of dedicated factories for wellness and pharma brands, the company said in a press release.
- Leumas raises $2.2 million seed funding to scale deeptech manufacturing and expand its factory-as-a-service model.
- Startup’s AI-powered robotic factories aim to revolutionize on-demand pharma and wellness manufacturing.
- Cyber-physical manufacturing technology by Leumas brings modular automation and regulatory compliance to the forefront.
Co-founded in 2016 by co-founders Subhajit Biswas and Nitesh K, Leumas provides on-demand manufacturing and factory-as-a-service models for wellness and pharma brands. Its offering is based on software-defined, modular robot factories that fundamentally change manufacturing and business outcomes from development to commercial production. By bringing together automation and, software intelligence (and R&D) it helps brands scale quickly, maintain quality and reduce risk.
Also Read: Wealthtech Firm PowerUp Money Wins $7.1 Million in First Institutional Funding
Leumas describes its core product as cyber-physical manufacturing technology: software-driven modular production lines that leverage AI-powered robotics, computer vision-based quality systems and autonomous operations – designed to provide optimal production output while maximizing regulatory compliance.
According to market analysis, the outsourced development and manufacturing market for pharma and wellness will top $400 billion by 2030.
